Our findings are consistent with a previous study showing that EEOS effectively induced apoptosis in human prostate cancer cells (LNCaP) through the down-regulation of BCL-2 and significant elevation of Caspase-9 and Caspase-3 activities in a dose-dependent manner [9]. The gene discussed is BCL2; the disease is prostate carcinoma.